Procurement of Pharmaceuticals

Title: Procurement of Pharmaceuticals

Office :

UNFPA – UKRAINE

Deadline :

09-July-24, 12:00 Kyiv time

Posted on :

25-June-24

Development Area :

Goods: Pharmaceuticals

Heading :

Procurement Process :

ITB – Invitation to Bid

Reference Number :

ITB Nº UNFPA/UKR/ITB/24/04

UNFPA hereby announces an invitation to bid for the procurement of the following goods: 

Pharmaceuticals

Bidding shall be conducted through ONE envelope. The technical bid containing the technical specifications and the financial bid containing price information shall be submitted together.

UNFPA CO Ukraine hereby solicits your Bid for the procurement of Pharmaceuticals as per the attached ITB No.UNFPA/UKR/ITB/24/04.

The bid shall reach UNFPA’s reception or the email inbox of [email protected] not later than 09 July 2024 by 12:00 Kyiv time. Bids received at this mailbox are kept undisclosed and shall not be opened before the scheduled opening date. Sending to any other email address will violate confidentiality and invalidate the bid.

Bids shall be prepared in accordance with ITB and shall include the requested documentation as per bid forms 1-5.

Electronic Submission:

Bidders shall make clear reference to the specific bid in the subject field as instructed, otherwise, bids may be rejected.

Clearly specify the following text in the subject line:

ITB No. UNFPA/UKR/ITB/24/04, Bidder’s Name. E-mail submission shall not exceed 20 MB, including the size of the cover email.

Partial bids are not allowed under this ITB.

The prices of the bid shall be valid for 90 days after the closing date of bid submission as specified by UNFPA. A bid valid for a shorter period shall be rejected by UNFPA.

The maximum allowed delivery time is 60 days upon issuing of purchase order.

All prices shall be quoted in US dollars (USD) including VAT if applicable.

The price of goods should include the delivery on a DAP (Kyiv, Ukraine) basis.

Please find more information in the attached ITB file and Annexes.

============================================================